The Healthcare team at ODDO BHF provides an expertise coverage of international sub-sectors and local players or industries in Pharma, Medtech, certain Services sectors – Biopharma, CDMO, Spec Pharma, Gx, APIs, CDMOs, CROs, IVD, CLIA Labs, certain Digital Health, Orthopedics and biomaterials and other medtech sectors.
Learn moreManaging Director
Joined ODDO BHF in 2022
Started his career at Arthur Andersen Paris for 5 years
He spent 10 years at Rothschild & Cie Paris
He then co-managed the Transaction R team at Rothschild Paris from 2007 to 2021
He graduated from Centrale Paris and INSEAD
Director
Joined ODDO BHF in 2020
Worked 2 years at Oaks Field Partners and 1 year at Natixis
Studied at AgroParisTech
€25-500M deals
Sell-side mandates / Selective buy-side mandates
Cross-border transactions
Carve-out, transmission of family-owned businesses
Special situations
Broad relationship with Private Equity funds
Banking facilities
Private Debt
Special situations
Bonds/EuroPP/Schuldschein
Convertible Bond
IPO
Block trades
Capital increases